NAVAMEDIC ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.1 NOK | -0.90% |
|
+1.53% | -9.81% |
| 05-06 | Navamedic Rolls Out Erectile Dysfunction Drug in Sweden | MT |
| 04-30 | Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 34.20 | 36.50 | 41.30 |
| Spread/Res. | -3.22% | -9.32% | -19.85% |
| Spread/Supp. | +2.16% | +2.16% | +4.42% |
| Support | 32.40 | 32.40 | 31.70 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- NAVA Stock
- Charts Navamedic ASA
